Effect of chronic lithium treatment on D2/3 autoreceptor regulation of dopaminergic function in the rat

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 2, 2008, Pages 218-225

  Ferrie, Lindsey J ^a   Gartside, Sarah E ^a   Martin, Katherine M ^a   Young, Allan H ^a   McQuade, Richard ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dopamine; Electrophysiology; In situ hybridization histochemistry; Lithium; Microdialysis; Nucleus accumbens; Ventral tegmental area

Indexed keywords

AMFEBUTAMONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE AUTORECEPTOR; LITHIUM CHLORIDE; MESSENGER RNA; SULPIRIDE; TD 80295;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DIALYSATE LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROCHEMICAL DETECTION; ELECTROPHYSIOLOGY; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; LONG TERM CARE; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; VENTRAL TEGMENTUM;

ANIMALS; AUTORECEPTORS; DOPAMINE; LITHIUM CHLORIDE; MALE; NUCLEUS ACCUMBENS; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER; SULPIRIDE; VENTRAL TEGMENTAL AREA;

RATTUS;

EID: 41849089298     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.10.013     Document Type: Article

References (32)

1. Basselin M., Chang L., Bell J.M., and Rapoport S.I. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology 30 (2005) 1064-1075
2. Basselin M., Chang L., and Rapoport S.I. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation. Psychopharmacology (Berl) 187 (2006) 303-311
3. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., and Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101 (2004) 5099-5104
4. Bosetti F., Seemann R., Bell J.M., Zahorchak R., Friedman E., Rapoport S.I., and Manickam P. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57 (2002) 205-209
5. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J.C., and Sokoloff P. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20 (2000) 8677-8684
6. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180 (1978) 545-580
7. Ferrie L., Young A.H., and McQuade R. Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. J Psychopharmacol 19 (2005) 229-234
8. Ferrie L., Young A.H., and McQuade R. Effect of lithium and lithium withdrawal on potassium evoked dopamine release and tyrosine hydroxylase expression in the rat. Int J Neuropsychopharmacol 9 (2006) 729-735
9. Gambarana C., Ghiglieri O., Masi F., Scheggi S., Tagliamonte A., and De Montis M.G. The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats. Brain Res 826 (1999) 200-209
10. Goodwin G.M. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164 (1994) 149-152
11. Grace A.A., and Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9 (1989) 3463-3481
12. Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105 (2001) 145-151
13. Greenwood T.A., Schork N.J., Eskin E., and Kelsoe J.R. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 11 115 (2006) 125-133
14. Guitart X., and Nestler E.J. Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J Neurochem 59 (1992) 1164-1167
15. Kiyatkin E.A., and Rebec G.V. Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience 85 (1998) 1285-1309
16. Koob G.F., and Swerdlow N.R. The functional output of the mesolimbic dopamine system. Ann N Y Acad Sci 537 (1988) 216-227
17. Lesch K.P., Aulakh C.S., Tolliver T.J., Hill J.L., Wolozin B.L., and Murphy D.L. Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain. Eur J Pharmacol 207 (1991) 355-359
18. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49 (1997) 231-252
19. Lopez A.D., and Murray C.C. The global burden of disease, 1990-2020. Nat Med 4 (1998) 1241-1243
20. Massat I., Souery D., Del-Favero J., Van Gestel S., Serretti A., Macciardi F., et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet 114 (2002) 177-185
21. McQuade R., Leitch M., Gartside S.E., and Young A.H. Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain. J Psychopharmacol 18 (2004) 496-501
22. McTavish S.F., McPherson M.H., Harmer C.J., Clark L., Sharp T., Goodwin G.M., et al. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 179 (2001) 356-360
23. Montezinho L.P., Castro M.M., Duarte C.B., Penschuck S., Geraldes C.F., and Mork A. The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents. J Neurochem 96 (2006) 1336-1348
24. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, Sydney
25. Pei Q., Leslie R.A., Grahame-Smith D.G., and Zetterstrom T.S. 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration. Neuroreport 6 (1995) 716-720
26. Severino G., Congiu D., Serreli C., De Lisa R., Chillotti C., Del Zompo M., et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 134 (2005) 37-38
27. Sidhpura N., Redfern P., and Wonnacott S. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices. Eur J Pharmacol 567 (2007) 102-109
28. Silverstone T. Dopamine in manic depressive illness. A pharmacological synthesis. J Affect Disord 8 (1985) 225-231
29. Slemmer J.E., Martin B.R., and Damaj M.I. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295 (2000) 321-327
30. Ungless M.A., Magill P.J., and Bolam J.P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303 (2004) 2040-2042
31. Yatham L.N., Liddle P.F., Lam R.W., Shiah I.S., Lane C., Stoessl A.J., et al. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 159 (2002) 1718-1723
32. Yim C.Y., and Mogenson G.J. Electrophysiological studies of neurons in the ventral tegmental area of Tsai. Brain Res 181 (1980) 301-313